COMP <GO>
NRC vs MRK // NET PROFIT MARGIN
NRC Health (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: NRC 2
— MRK 10
▲ NET PROFIT MARGIN LEADER: MRK
LAST: $23.49 (+0.09%) • MKT CAP: $519.6M
net-margins
8.40%
LAST: $146.33 (+3.83%) • MKT CAP: $361.02B
net-margins
28.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NRC VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NRC | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 74.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 21.00% | 20.70% | +0.30 | NRC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.6x | 15.3x | +3.30 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 3.03% | 3.42% | -0.39 | MRK | /fcf-yield <GO> |
| Operating Margin | 16.40% | 34.30% | -17.90 | MRK | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 8.40% | 28.10% | -19.70 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | -4.00% | 1.30% | -5.30 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.11% | 2.26% | -0.15 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.82 | 5.19 | -1.37 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.6 | 51.7 | +11.90 | NRC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 41.7x | 18.4x | +23.30 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $519.6M | $361.02B | -$360.50B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NRC REV | MRK REV | NRC GROSS % | MRK GROSS % | NRC FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $137.4M | $65.01B | — | 74.8% | $15.7M | $12.36B |
| FY 2024 | $143.1M | $64.17B | — | 76.3% | $19.2M | $18.10B |
| FY 2023 | $148.6M | $60.12B | — | — | $38.1M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NRC // BETA —
MRK // BETA 0.92